Outcomes of Total Arterial Coronary Artery Bypass Grafting

University of Glasgow

Overview

"real-life" retrospective multicentric database for the analysis of the long term outcomes of total arterial CABG in comparison to saphenous vein based CABG

This aim of this registry is to create a multi centric database for the analysis of basic long term outcomes and immediate postoperative outcomes of total arterial CABG in comparison to saphenous vein based CABG. The registry will include both on pump and off pump surgery. The registry is intended to capture the "real-life" picture of the CABG scenario among centers worldwide

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease Surgical Wound Infection

Interventions

coronary artery bypass grafting (CABG)PROCEDURE

myocardial revascularization

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * elective CABG patients (on pump or off pump surgery; pedicles of skletonized internal mammary artery harvesting technique; open or endoscopic vein harvesting technique) Exclusion Criteria: * urgent or emergent CABG * concomitant procedures * redo cases

Locations (4)

Campus St Ian

Genk, Belgium

University Campus Bio-Medico

Rome, Italy

Thoracic Centrum Twente

Enschede, Netherlands

Golden Jubilee National Hospital

Glasgow, United Kingdom

Outcomes

Primary Outcomes

Survival

Long term survival

Time frame: data collection every year up to 5 years after operation/entry in the registry

MACCEs

Major cardiac events (myocardial infarction, stroke, readmission for CHF)

Time frame: data collection every year up to 5 years after operation/entry in the registry

target vessel revascularization

readmission for revascularization due to graft failure

Time frame: data collection every year up to 5 years after operation/entry in the registry

Wound infection

Readmission for wound infection (superficial sternal wound infection, deep sternal wound infection, saphenous vein related wound infection, need for VAC therapy, need for surgical debridment, need for prolonged antibiotic therapy)

Time frame: data collection every year up to 5 years after operation/entry in the registry

Secondary Outcomes

Blood product usage

unit of concentrated red cells, fresh frozen plasma, platelets

Time frame: perioperative (in hospital)

Bleeding

surgical bleeding requiring re-exploration

Time frame: perioperative (in hospital)

Length of ICU stay

number of days in ICU

Time frame: perioperative (in hospital)

Length of hospital stay

number of days in hospital

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.